Serotonin API Manufacturers & Suppliers
0 verified resultsCommercial-scale Suppliers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.






Serotonin | CAS No: 50-67-9 | GMP-certified suppliers
A medication that modulates mood, anxiety, cognition, and gastrointestinal functions for potential use in central nervous system and peripheral disorders.
Therapeutic categories
Product Snapshot
- Serotonin is typically formulated as an oral small molecule or nutraceutical product
- Its primary applications include supporting mood regulation and other neurochemical functions
- Currently, serotonin-based products are classified as investigational or nutraceuticals without formal FDA or EMA approval
Clinical Overview
Pharmacologically, serotonin acts as a neurotransmitter and autacoid involved in modulating mood, anxiety, cognition, vascular tone, and gastrointestinal motility. Despite its classification among antidepressive agents and serotonergic drugs, specific mechanisms of action, receptor subtype interactions, and pharmacodynamic profiles are not detailed in regulatory or clinical databases for the pure compound as an isolated pharmaceutical active ingredient.
Serotonin’s mechanism of action is generally understood to involve binding to multiple serotonin receptor subtypes (5-HT receptors), which mediate its diverse neurological and systemic effects. The compound’s role in modulating synaptic transmission underlies its implication in mood regulation, anxiety, and related neurophysiological processes.
Key ADME (absorption, distribution, metabolism, and excretion) parameters for serotonin as a pharmaceutical agent are not extensively characterized due to its endogenous nature and limited direct therapeutic use. Serotonin is rapidly metabolized primarily by monoamine oxidase enzymes and excreted renally. Its bioavailability and systemic exposure are influenced by serotonergic pathway activity and metabolic capacity.
Safety and toxicity considerations emphasize that serotonin and serotonergic drugs are associated with risks such as serotonin syndrome, a potentially life-threatening condition resulting from excessive serotonergic activity. The compound listed here is noted as a homeopathic product for symptomatic relief of nervousness, anxiety, mood swings, joint pains, weakness, drowsiness, itching, and lethargy; it lacks FDA evaluation for these uses and should be differentiated from clinically approved serotonergic pharmaceuticals.
In pharmaceutical research and manufacturing contexts, serotonin is often used as a reference substance or investigational nutraceutical. Quality considerations for API procurement include sourcing from suppliers complying with pharmacopoeial standards and ensuring consistency in purity, stability, and absence of contaminants. Due to its biological significance, analytical characterization should confirm identity and assay parameters aligned with intended investigational or formulation purposes.
Identification & chemistry
| Generic name | Serotonin |
|---|---|
| Molecule type | Small molecule |
| CAS | 50-67-9 |
| UNII | 333DO1RDJY |
| DrugBank ID | DB08839 |
Pharmacology
Targets
| Target | Organism | Actions |
|---|---|---|
| Sodium-dependent serotonin transporter | Humans | |
| 5-hydroxytryptamine receptor 2A | Humans | |
| 5-hydroxytryptamine receptor 3A | Humans |
Formulation & handling
- Serotonin is a small molecule with moderate water solubility suitable for oral formulation development.
- Its low LogP value indicates limited lipophilicity, influencing membrane permeability considerations.
- Stability should be assessed under physiological pH due to its phenolic hydroxyl group and amine functional groups.
Regulatory status
Serotonin is a type of Anti-anxiety
The Anti-anxiety category in the pharmaceutical API (Active Pharmaceutical Ingredient) market refers to a group of substances specifically developed to alleviate symptoms associated with anxiety disorders. Anxiety disorders are mental health conditions characterized by excessive worry, fear, and unease that can significantly impact daily life.
Pharmaceutical APIs within the Anti-anxiety category work by modulating the activity of neurotransmitters in the brain, particularly gamma-aminobutyric acid (GABA). GABA is an inhibitory neurotransmitter that helps regulate the excitability of neurons. By enhancing GABA's inhibitory effects, these APIs promote a calming effect, reducing anxiety symptoms.
Common Anti-anxiety APIs include benzodiazepines, such as alprazolam, diazepam, and lorazepam. These substances act as central nervous system depressants, inducing sedation and relaxation. Other APIs in this category include selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and certain antihistamines.
Pharmaceutical companies develop and manufacture Anti-anxiety APIs to meet the growing demand for effective anxiety treatment options. These APIs are typically used as the active ingredient in the production of various anti-anxiety medications, such as tablets, capsules, or liquid formulations.
The market for Anti-anxiety APIs is influenced by factors such as increasing awareness about mental health, rising prevalence of anxiety disorders, and the growing demand for personalized treatment options. Regulatory compliance, quality control, and safety are crucial considerations in the development and production of these APIs to ensure efficacy and minimize potential side effects.
Overall, Anti-anxiety APIs play a vital role in the pharmaceutical industry by providing effective solutions for individuals struggling with anxiety disorders, enhancing their quality of life, and promoting overall well-being.
